Trades on 3 secondary markets

Sonoma Biotherapeutics

Sonoma Biotherapeutics is a clinical-stage biopharmaceutical company developing engineered regulatory T cell (Treg) therapies to restore immune balance in autoimmune and inflammatory diseases. Building on Nobel Prize-winning Treg biology, its lead program SBT-77-7101 is in Phase 1 clinical trials fo

minimal 6.8 / 100 0 APIs View provider profile →

Company Biotech Cell Therapy Immunology Autoimmune Biopharmaceutical

Sonoma Biotherapeutics is an API provider whose private shares are listed on 3 secondary markets: Forge Global, Hiive, Nasdaq Private Market.

Where It Trades

F Forge Global View listing → H Hiive View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.